Research programme: hypoxia-inducible factor 2 alpha inhibitors - Schrodinger/Bristol Myers Squibb
Alternative Names: HIF-2a; HIF2α inhibitors - Schrodinger; SDGR4 program - Schrodinger; SDGR4-HIF-2αLatest Information Update: 28 Jan 2024
At a glance
- Originator Schrodinger
- Class Antineoplastics; Small molecules
- Mechanism of Action Endothelial PAS domain-containing protein 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Renal cell carcinoma